|2005N-0345|| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product|
|FDA Comment Number :||EC871|
|Submitter :||Ms. Pat LeMond||Date & Time:||10/17/2005 10:10:01|
|Organization :||Ms. Pat LeMond|
|Category :||Individual Consumer|
| See Attachment:
As you review the data on Plan B, we urge you to consider that a woman's access to EC plays a critical role in preventing unintended pregnancy and reducing the need for abortion. We support the approval of Barr Laboratories' application. Thank you for your consideration of this request.